A previous study showed that the NLR family pyrin domain containing 3 (NLRP3) inflammasome components were significantly increased in NASH patients compared to non-NASH/NAFLD patients (Wree et al., 2014). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.